Citations

Showing 10 of 108104 citations.

Emerging Paradigms in Chronic Kidney Ischemia
Eirin, Alfonso , Textor, Stephen C., Lerman, Lilach O. , Eirin, Alfonso

Mayo Clinic

Hypertension | October 10, 2018 | Volume: 72 | Issue: 5 | Pages: 1023-1030

10.1161/hypertensionaha.118.11082 | PMID 30354824 Get It

Coexistent bicuspid aortic valve and mitral valve prolapse: epidemiology, phenotypic spectrum, and clinical implications
Padang, Ratnasari , Enriquez‐Sarano, Maurice , Pislaru, Sorin V. , Maalouf, Joseph F., Mankad, Sunil , Maltais, Simon, Suri, Rakesh M. , Mankad, Sunil V., Sabbah, Michael S. , Enriquez-Sarano, Maurice , Nkomo, Vuyisile T. , Schaff, Hartzell V. , Michelena, Héctor I.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | October 10, 2018 | Volume: 20 | Issue: 6 | Pages: 677-686

10.1093/ehjci/jey166 | PMID 30445616 Get It

NucMap: a database of genome-wide nucleosome positioning map across species
Zhao, Yongbing , Wang, Jinyue , Zhang, Hao , Jiang, Meiye , Zhang, Zhewen , Bào, Yīmíng , Zhang, Zhang , Wu, Jiayan , Asmann, Yan W. , Li, Rujiao , Xiao, Jingfa , Fang, Liang , Liu, Yanxia , Wang, Qi , Zhao, Wenming

Mayo Clinic

Nucleic Acids Research | October 10, 2018 | Volume: 47 | Issue: D1 | Pages: D163-D169

10.1093/nar/gky980 | PMID 30335176 Get It

Never Events in Radiology and Strategies to Reduce Preventable Serious Adverse Events
Ponce, Lisa , Osborn, Howard H., Jokerst, Clinton, Ponce, Lisa M, Flug, Jonathan A.

Mayo Clinic

RadioGraphics | October 10, 2018 | Volume: 38 | Issue: 6 | Pages: 1823-1832

10.1148/rg.2018180036 | PMID 30303781 Get It

The Late-Career Radiologist: Options and Opportunities
Bluth, Edward I. , Goodman, T. Robin, Bender, Claire E.

Mayo Clinic

RadioGraphics | October 10, 2018 | Volume: 38 | Issue: 6 | Pages: 1617-1625

10.1148/rg.2018180015 | PMID 30303783 Get It

Comparison of bleach, acetic acid, and other topical anti‐infective treatments in pediatric atopic dermatitis: A retrospective cohort study on antibiotic exposure
Asch, Sarah , Vork, Diana L. , Joseph, Josiane , Major‐Elechi, Brittny , Tollefson, Megha M.

Mayo Clinic

Pediatric Dermatology | October 10, 2018 | Volume: 36 | Issue: 1 | Pages: 115-120

10.1111/pde.13663 | PMID 30303549 Get It

AbstractBackground/ObjectivesSkin infection is common in atopic dermatitis (AD), often necessitating treatment with systemic antibiotics. Topical adjunctive therapies such as dilute bleach baths are increasingly recommended, and topical dilute acetic acid (AA) has not been widely studied. The objective of this study was to evaluate whether various topical anti‐infective bathing recommendations were associated with decreased systemic antibiotic exposure in pediatric AD, as well as evaluate topical anti‐infective recommendations over time within our institution.MethodsClinical data were extracted from charts of pediatric patients from 1/1/2000 to 12/31/2005 and 1/1/2009 to 12/31/2014 who visited outpatient dermatology clinics at Mayo Clinic, Rochester, a tertiary referral center. Recommendations for topical anti‐infectives (dilute AA, dilute bleach, other, or none) at any time after patient had clinically proven or suspected AD superinfection were recorded as exposures to topical anti‐infective. Primary outcome was the number of systemic antibiotic courses in a 1‐year period.ResultsOf 1111 patients with AD, 753 met inclusion criteria (303 in 2000‐2005; 450 in 2009‐2014). Of these, 351 (46.6%) had culture‐proven or clinically suspected superinfection. Topical anti‐infective recommendations increased between the time periods (23.3% to 79.2%; P < 0.001) and number of courses of systemic antibiotics decreased (1.9 per year vs 1.5 per year, P = 0.010). Number of systemic antibiotic courses did not differ between those who received bathing recommendations and those who did not, nor between different anti‐infective groups (P = 0.398).ConclusionsPractice behaviors have changed, and topical anti‐infectives are now commonly recommended. Neither dilute AA nor bleach baths were associated with fewer subsequent exposures to systemic antibiotics in the treatment of pediatric AD.
The Road to Wellness: Engagement Strategies to Help Radiologists Achieve Joy at Work
Fishman, Michael , Siewert, Bettina , Bender, Claire E., Kruskal, Jonathan B. , Fishman, Michael D C, Mehta, Tejas S, Siewert, Bettina , Kruskal, Jonathan B , Mehta, Tejas S.

Mayo Clinic

RadioGraphics | October 10, 2018 | Volume: 38 | Issue: 6 | Pages: 1651-1664

10.1148/rg.2018180030 | PMID 30303794 Get It

Physiology in Perspective: Understanding the Aging Process
Sieck, Gary C.

Mayo Clinic

Physiology | October 10, 2018 | Volume: 33 | Issue: 6 | Pages: 372-373

10.1152/physiol.00042.2018 | PMID 30303774 Get It

Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging
Rocca, Walter A. , Rocca, Liliana Gazzuola , Shuster, Lynne T., Kirkland, James L. , Schafer, Marissa , Mielke, Michelle M. , Kantarci, Kejal , Miller, Virginia M. , Gazzuola Rocca, Liliana, Smith, Carin Y. , Grossardt, Brandon R. , Schafer, Marissa J, Mielke, Michelle M , Kantarci, Kejal , Schafer, Marissa J , Faubion, Stephanie S. , LeBrasseur, Nathan K. , Stewart, Elizabeth A.

Mayo Clinic

Physiology | October 10, 2018 | Volume: 33 | Issue: 6 | Pages: 374-383

10.1152/physiol.00024.2018 | PMID 30303778 Get It

Bilateral oophorectomy in premenopausal women is a unique condition causing the abrupt and premature loss of ovarian hormones, primarily estrogen. Bilateral oophorectomy causes an alteration of several fundamental aging processes at the cellular, tissue, organ, and system levels, leading to multimorbidity, frailty, and reduced survival. However, many questions remain unanswered.
The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union
Jannetto, Paul J. , Helander, Anders , Garg, Uttam, Janis, Gregory C., Goldberger, Bruce A. , Ketha, Hemamalini

Mayo Clinic

Clinical Chemistry | October 10, 2018 | Volume: 65 | Issue: 2 | Pages: 242-253

10.1373/clinchem.2017.281626 | PMID 30305277 Get It

Abstract BACKGROUND Since 2013, an unprecedented surge in fentanyl overdose deaths has been caused by heroin laced with illicitly produced fentanyl and/or fentanyl analogs (FAs) sold as heroin. The US Drug Enforcement Agency's National Forensic Laboratory Information System reported a &gt;300% increase in fentanyl encounters from 4697 in 2014 to 14440 in 2015. In 2015, the CDC reported 9580 deaths caused by synthetic opioids, primarily fentanyl, a 72% increase from 2014. The European Monitoring Centre for Drugs and Drug Addiction has also encountered several new FAs in the heroin supply. Counterfeit pharmaceuticals containing mixtures of fentanyl and FAs continue to be a poorly recognized worldwide problem despite the WHO classifying several FAs as a serious threat to public health. CONTENT This review covers the epidemiology of fentanyl abuse and discusses the clinical practice implications of widespread fentanyl abuse. It includes a historical perspective on the illicit FAs that have appeared in the US and European Union and reviews the methods available to identify FAs and emerging technologies useful for identifying previously undescribed analogs. A compilation of structural and mass spectral data on FAs reported thus far is provided. SUMMARY Fentanyl and FAs have evolved into a global public health threat. It is important to understand the analytical, clinical, and regulatory efforts underway to assist communities affected by the current fentanyl epidemic.